Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiography, Dual-Energy Scanned Projection | 23 | 2021 | 200 | 7.770 |
Why?
|
Tomography, X-Ray Computed | 81 | 2021 | 20556 | 3.780 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 24 | 2021 | 1222 | 2.690 |
Why?
|
Radiography, Abdominal | 13 | 2020 | 534 | 2.650 |
Why?
|
Carcinoma, Pancreatic Ductal | 7 | 2021 | 1727 | 2.170 |
Why?
|
Urolithiasis | 6 | 2019 | 125 | 2.100 |
Why?
|
Pancreatic Neoplasms | 12 | 2021 | 5369 | 1.990 |
Why?
|
Contrast Media | 41 | 2021 | 5305 | 1.900 |
Why?
|
Iodine | 8 | 2021 | 287 | 1.890 |
Why?
|
Liver Neoplasms | 15 | 2020 | 4309 | 1.610 |
Why?
|
Abdomen | 7 | 2020 | 1128 | 1.510 |
Why?
|
Adenocarcinoma | 8 | 2020 | 6345 | 1.340 |
Why?
|
Carcinoma, Hepatocellular | 7 | 2020 | 2292 | 1.180 |
Why?
|
Body Size | 3 | 2019 | 463 | 1.050 |
Why?
|
Radiation Dosage | 11 | 2021 | 1956 | 0.930 |
Why?
|
Artifacts | 7 | 2021 | 1910 | 0.880 |
Why?
|
Crohn Disease | 5 | 2020 | 2279 | 0.870 |
Why?
|
Perfusion Imaging | 3 | 2015 | 196 | 0.840 |
Why?
|
Abdominal Neoplasms | 3 | 2019 | 287 | 0.820 |
Why?
|
Diverticulitis, Colonic | 2 | 2021 | 138 | 0.800 |
Why?
|
Deglutition Disorders | 2 | 2019 | 627 | 0.790 |
Why?
|
Urinary Calculi | 3 | 2019 | 90 | 0.780 |
Why?
|
Gastrointestinal Diseases | 2 | 2020 | 1202 | 0.780 |
Why?
|
Abdominal Pain | 7 | 2020 | 1070 | 0.770 |
Why?
|
Diagnostic Imaging | 7 | 2020 | 3527 | 0.750 |
Why?
|
Radiation Protection | 3 | 2013 | 424 | 0.630 |
Why?
|
Kidney Calculi | 4 | 2016 | 463 | 0.630 |
Why?
|
Urography | 2 | 2017 | 316 | 0.630 |
Why?
|
Kidney Neoplasms | 5 | 2020 | 4252 | 0.610 |
Why?
|
Radiographic Image Enhancement | 7 | 2019 | 876 | 0.560 |
Why?
|
Pancreatitis, Chronic | 1 | 2020 | 288 | 0.560 |
Why?
|
Magnetic Resonance Imaging | 17 | 2020 | 36401 | 0.560 |
Why?
|
Multiple Endocrine Neoplasia | 1 | 2016 | 25 | 0.530 |
Why?
|
Gallbladder Neoplasms | 2 | 2021 | 189 | 0.500 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2021 | 732 | 0.500 |
Why?
|
Pancreas | 4 | 2021 | 1691 | 0.480 |
Why?
|
Metals | 1 | 2019 | 719 | 0.470 |
Why?
|
Humans | 121 | 2021 | 760740 | 0.460 |
Why?
|
Ultrasonography | 7 | 2018 | 5965 | 0.450 |
Why?
|
Retrospective Studies | 39 | 2021 | 80583 | 0.440 |
Why?
|
Fiducial Markers | 1 | 2015 | 132 | 0.440 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2020 | 875 | 0.440 |
Why?
|
Immunotherapy | 2 | 2020 | 4642 | 0.440 |
Why?
|
Urinary Tract | 1 | 2016 | 313 | 0.430 |
Why?
|
Portal Vein | 4 | 2020 | 431 | 0.420 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2016 | 571 | 0.410 |
Why?
|
Radiography, Interventional | 4 | 2017 | 1120 | 0.400 |
Why?
|
Aged, 80 and over | 33 | 2021 | 58919 | 0.400 |
Why?
|
Diagnosis, Differential | 18 | 2021 | 12966 | 0.400 |
Why?
|
Cranial Fossa, Middle | 1 | 2012 | 29 | 0.400 |
Why?
|
Prostheses and Implants | 1 | 2019 | 1269 | 0.400 |
Why?
|
Neuroendocrine Tumors | 1 | 2018 | 641 | 0.390 |
Why?
|
Mesenchymoma | 1 | 2012 | 49 | 0.390 |
Why?
|
Celiac Plexus | 1 | 2011 | 32 | 0.390 |
Why?
|
Documentation | 1 | 2018 | 896 | 0.380 |
Why?
|
Middle Aged | 62 | 2021 | 220603 | 0.380 |
Why?
|
Sarcoma | 4 | 2015 | 1800 | 0.370 |
Why?
|
Autonomic Nerve Block | 1 | 2011 | 80 | 0.370 |
Why?
|
Evidence-Based Medicine | 10 | 2020 | 3680 | 0.360 |
Why?
|
Pain, Intractable | 1 | 2011 | 132 | 0.360 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2011 | 70 | 0.360 |
Why?
|
Prosthesis Implantation | 1 | 2015 | 591 | 0.350 |
Why?
|
Surgery, Computer-Assisted | 2 | 2015 | 1002 | 0.350 |
Why?
|
Sensitivity and Specificity | 11 | 2021 | 14649 | 0.350 |
Why?
|
Cholelithiasis | 1 | 2011 | 407 | 0.350 |
Why?
|
Early Detection of Cancer | 4 | 2020 | 3196 | 0.340 |
Why?
|
Aged | 49 | 2021 | 169092 | 0.340 |
Why?
|
Polyps | 1 | 2011 | 200 | 0.340 |
Why?
|
Radiology | 2 | 2020 | 2113 | 0.340 |
Why?
|
Intestines | 1 | 2018 | 1909 | 0.330 |
Why?
|
Sarcopenia | 3 | 2018 | 370 | 0.320 |
Why?
|
Pelvic Neoplasms | 1 | 2011 | 247 | 0.320 |
Why?
|
Skull Base Neoplasms | 1 | 2012 | 270 | 0.310 |
Why?
|
Male | 66 | 2021 | 360402 | 0.300 |
Why?
|
Microspheres | 1 | 2011 | 782 | 0.290 |
Why?
|
Iopamidol | 3 | 2018 | 186 | 0.290 |
Why?
|
Lymphoma | 1 | 2016 | 1899 | 0.290 |
Why?
|
Camptothecin | 1 | 2011 | 591 | 0.280 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2863 | 0.280 |
Why?
|
Gadolinium DTPA | 2 | 2020 | 823 | 0.280 |
Why?
|
Colonography, Computed Tomographic | 2 | 2019 | 170 | 0.280 |
Why?
|
Algorithms | 6 | 2021 | 14024 | 0.270 |
Why?
|
Female | 64 | 2021 | 392203 | 0.270 |
Why?
|
Esophageal Neoplasms | 1 | 2016 | 1657 | 0.270 |
Why?
|
Adult | 44 | 2021 | 220995 | 0.260 |
Why?
|
Positron-Emission Tomography | 4 | 2016 | 6483 | 0.250 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2016 | 2789 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3209 | 0.250 |
Why?
|
Artificial Intelligence | 1 | 2020 | 2575 | 0.250 |
Why?
|
Societies, Medical | 8 | 2020 | 3901 | 0.250 |
Why?
|
Carcinoma, Renal Cell | 1 | 2020 | 3164 | 0.240 |
Why?
|
Neoplasms | 5 | 2021 | 22131 | 0.230 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2021 | 8998 | 0.230 |
Why?
|
Neoplasm Staging | 4 | 2020 | 11118 | 0.230 |
Why?
|
Barium Sulfate | 2 | 2017 | 180 | 0.220 |
Why?
|
Predictive Value of Tests | 10 | 2019 | 15250 | 0.210 |
Why?
|
Reproducibility of Results | 10 | 2021 | 20077 | 0.210 |
Why?
|
Angiogenesis Inhibitors | 5 | 2015 | 2048 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.200 |
Why?
|
Ureteral Calculi | 2 | 2017 | 114 | 0.200 |
Why?
|
Colitis, Ulcerative | 3 | 2019 | 1921 | 0.200 |
Why?
|
Kidney Medulla | 2 | 2014 | 169 | 0.190 |
Why?
|
Feasibility Studies | 4 | 2021 | 5239 | 0.190 |
Why?
|
Biliary Tract Neoplasms | 2 | 2015 | 185 | 0.180 |
Why?
|
Barium | 2 | 2019 | 62 | 0.180 |
Why?
|
Physicians | 1 | 2018 | 4583 | 0.180 |
Why?
|
Gastrostomy | 2 | 2015 | 323 | 0.180 |
Why?
|
Obesity | 3 | 2019 | 12934 | 0.170 |
Why?
|
Cryptococcus neoformans | 1 | 2020 | 120 | 0.170 |
Why?
|
Cryptococcosis | 1 | 2020 | 103 | 0.170 |
Why?
|
Abdominal Cavity | 1 | 2019 | 34 | 0.170 |
Why?
|
Antineoplastic Agents | 3 | 2017 | 13635 | 0.170 |
Why?
|
Colorectal Neoplasms | 4 | 2020 | 6927 | 0.170 |
Why?
|
Enterocolitis | 1 | 2020 | 106 | 0.160 |
Why?
|
Iodine Compounds | 1 | 2018 | 28 | 0.160 |
Why?
|
Whole Body Imaging | 1 | 2021 | 283 | 0.160 |
Why?
|
Image Interpretation, Computer-Assisted | 5 | 2018 | 3356 | 0.160 |
Why?
|
Colon | 2 | 2019 | 1791 | 0.150 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7390 | 0.150 |
Why?
|
Diverticulitis | 1 | 2021 | 185 | 0.150 |
Why?
|
Abdomen, Acute | 1 | 2018 | 122 | 0.150 |
Why?
|
Ureteroscopy | 2 | 2017 | 146 | 0.150 |
Why?
|
Laparotomy | 1 | 2020 | 456 | 0.150 |
Why?
|
Osteochondroma | 1 | 2007 | 44 | 0.140 |
Why?
|
Utilization Review | 1 | 2019 | 382 | 0.140 |
Why?
|
Lipomatosis, Multiple Symmetrical | 1 | 2007 | 8 | 0.140 |
Why?
|
Software | 6 | 2018 | 4432 | 0.140 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2020 | 507 | 0.140 |
Why?
|
Iliac Artery | 1 | 2018 | 343 | 0.140 |
Why?
|
Vagus Nerve Diseases | 1 | 2006 | 5 | 0.140 |
Why?
|
Mandibular Condyle | 1 | 2007 | 115 | 0.140 |
Why?
|
Adolescent | 12 | 2020 | 88247 | 0.140 |
Why?
|
Image Enhancement | 4 | 2012 | 2881 | 0.140 |
Why?
|
Pharyngeal Neoplasms | 1 | 2007 | 113 | 0.140 |
Why?
|
United States | 12 | 2020 | 72292 | 0.140 |
Why?
|
Mesentery | 1 | 2017 | 202 | 0.140 |
Why?
|
Omentum | 1 | 2017 | 167 | 0.140 |
Why?
|
Mandibular Neoplasms | 1 | 2007 | 130 | 0.140 |
Why?
|
Neoadjuvant Therapy | 4 | 2015 | 2827 | 0.140 |
Why?
|
Young Adult | 11 | 2020 | 59191 | 0.130 |
Why?
|
Aorta, Abdominal | 1 | 2018 | 625 | 0.130 |
Why?
|
Neovascularization, Pathologic | 4 | 2015 | 2644 | 0.130 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2016 | 214 | 0.130 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2006 | 134 | 0.120 |
Why?
|
Ureteral Obstruction | 1 | 2017 | 293 | 0.120 |
Why?
|
Immunocompromised Host | 1 | 2020 | 858 | 0.120 |
Why?
|
Gastrointestinal Tract | 1 | 2020 | 834 | 0.120 |
Why?
|
Ethanol | 2 | 2011 | 1320 | 0.120 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2016 | 186 | 0.110 |
Why?
|
Colonic Polyps | 1 | 2019 | 553 | 0.110 |
Why?
|
Steroids | 1 | 2019 | 928 | 0.110 |
Why?
|
Phenylurea Compounds | 1 | 2016 | 529 | 0.110 |
Why?
|
Tumor Burden | 2 | 2017 | 1892 | 0.110 |
Why?
|
Connective Tissue | 1 | 2015 | 419 | 0.110 |
Why?
|
Radiography, Thoracic | 1 | 2020 | 1302 | 0.110 |
Why?
|
Ablation Techniques | 1 | 2016 | 246 | 0.110 |
Why?
|
Goiter, Endemic | 1 | 2002 | 3 | 0.110 |
Why?
|
Salts | 1 | 2002 | 63 | 0.100 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 899 | 0.100 |
Why?
|
Salvage Therapy | 1 | 2019 | 1263 | 0.100 |
Why?
|
Cholecystolithiasis | 1 | 2011 | 7 | 0.100 |
Why?
|
Liver | 4 | 2020 | 7512 | 0.100 |
Why?
|
Zygoma | 1 | 2012 | 52 | 0.100 |
Why?
|
Gene Amplification | 1 | 2016 | 1087 | 0.100 |
Why?
|
Appendicitis | 1 | 2018 | 675 | 0.100 |
Why?
|
Phenol | 1 | 2011 | 44 | 0.100 |
Why?
|
Cholangiocarcinoma | 1 | 2016 | 553 | 0.090 |
Why?
|
Bile Duct Neoplasms | 1 | 2016 | 606 | 0.090 |
Why?
|
Neurilemmoma | 1 | 2006 | 524 | 0.090 |
Why?
|
Injections | 2 | 2011 | 832 | 0.090 |
Why?
|
Rhabdomyolysis | 1 | 2012 | 152 | 0.090 |
Why?
|
Device Removal | 1 | 2015 | 629 | 0.090 |
Why?
|
Diatrizoate Meglumine | 1 | 2010 | 79 | 0.090 |
Why?
|
Esophagus | 1 | 2016 | 1031 | 0.090 |
Why?
|
Surgical Mesh | 1 | 2013 | 311 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2020 | 2057 | 0.090 |
Why?
|
Quadriceps Muscle | 1 | 2012 | 155 | 0.090 |
Why?
|
Treatment Outcome | 9 | 2018 | 64572 | 0.090 |
Why?
|
Technology, Radiologic | 1 | 2011 | 160 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1405 | 0.090 |
Why?
|
Vascular Diseases | 1 | 2019 | 1159 | 0.090 |
Why?
|
Maxillary Sinus | 1 | 2012 | 180 | 0.090 |
Why?
|
Acute Disease | 1 | 2021 | 7236 | 0.090 |
Why?
|
Colonoscopy | 1 | 2018 | 1397 | 0.090 |
Why?
|
Prospective Studies | 7 | 2021 | 54364 | 0.090 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2017 | 955 | 0.080 |
Why?
|
Molecular Imaging | 1 | 2016 | 814 | 0.080 |
Why?
|
Simvastatin | 1 | 2012 | 346 | 0.080 |
Why?
|
Cholecystectomy | 1 | 2011 | 406 | 0.080 |
Why?
|
Necrosis | 2 | 2011 | 1610 | 0.080 |
Why?
|
Subtraction Technique | 1 | 2012 | 512 | 0.080 |
Why?
|
Colectomy | 3 | 2019 | 686 | 0.080 |
Why?
|
Gallstones | 1 | 2011 | 284 | 0.080 |
Why?
|
Scattering, Radiation | 1 | 2011 | 490 | 0.080 |
Why?
|
Cystadenoma, Serous | 1 | 2009 | 100 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2018 | 11735 | 0.080 |
Why?
|
Swine | 4 | 2011 | 5908 | 0.080 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 2 | 2015 | 1655 | 0.080 |
Why?
|
Organoplatinum Compounds | 3 | 2018 | 407 | 0.070 |
Why?
|
Meningioma | 1 | 2007 | 1215 | 0.070 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2015 | 943 | 0.070 |
Why?
|
Uterine Neoplasms | 1 | 2016 | 1420 | 0.070 |
Why?
|
Emergencies | 3 | 2019 | 1217 | 0.070 |
Why?
|
Quality Control | 2 | 2021 | 831 | 0.070 |
Why?
|
Ultrasonography, Interventional | 2 | 2017 | 1496 | 0.070 |
Why?
|
Temporal Bone | 1 | 2012 | 683 | 0.070 |
Why?
|
Intestine, Small | 1 | 2013 | 1207 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5493 | 0.070 |
Why?
|
Linear Models | 1 | 2017 | 5866 | 0.070 |
Why?
|
Mandible | 1 | 2012 | 753 | 0.070 |
Why?
|
Venous Thrombosis | 1 | 2016 | 1303 | 0.070 |
Why?
|
Obesity, Morbid | 1 | 2018 | 1276 | 0.070 |
Why?
|
Paralysis | 1 | 2008 | 250 | 0.070 |
Why?
|
Injections, Intravenous | 1 | 2009 | 1376 | 0.070 |
Why?
|
Mass Screening | 2 | 2020 | 5425 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 4058 | 0.070 |
Why?
|
Radiology Information Systems | 1 | 2011 | 529 | 0.070 |
Why?
|
Ureter | 1 | 2008 | 368 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2015 | 2008 | 0.060 |
Why?
|
Radiometry | 1 | 2011 | 812 | 0.060 |
Why?
|
Time Factors | 6 | 2018 | 39908 | 0.060 |
Why?
|
Kidney | 2 | 2019 | 7044 | 0.060 |
Why?
|
Workload | 1 | 2011 | 844 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2019 | 9277 | 0.060 |
Why?
|
Pancreatectomy | 1 | 2009 | 811 | 0.060 |
Why?
|
Pyrimidines | 1 | 2016 | 3027 | 0.060 |
Why?
|
Radiopharmaceuticals | 2 | 2015 | 2650 | 0.060 |
Why?
|
Urban Population | 1 | 2002 | 2034 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9313 | 0.060 |
Why?
|
Biological Products | 1 | 2013 | 912 | 0.060 |
Why?
|
Edema | 1 | 2008 | 765 | 0.060 |
Why?
|
Prognosis | 3 | 2020 | 29601 | 0.050 |
Why?
|
Pandemics | 2 | 2020 | 8652 | 0.050 |
Why?
|
Fatty Liver | 1 | 2009 | 787 | 0.050 |
Why?
|
Fluoroscopy | 2 | 2018 | 945 | 0.050 |
Why?
|
Genetic Testing | 1 | 2016 | 3533 | 0.050 |
Why?
|
Risk Factors | 5 | 2021 | 74128 | 0.050 |
Why?
|
Risk Assessment | 3 | 2020 | 23974 | 0.050 |
Why?
|
Pancreatitis | 1 | 2009 | 1097 | 0.050 |
Why?
|
Endoscopy | 2 | 2009 | 1851 | 0.050 |
Why?
|
Hospitalization | 2 | 2019 | 10708 | 0.050 |
Why?
|
Treatment Failure | 2 | 2019 | 2635 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2016 | 5304 | 0.050 |
Why?
|
Soft Tissue Neoplasms | 1 | 2010 | 1158 | 0.050 |
Why?
|
Child | 5 | 2018 | 80089 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39062 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2021 | 26183 | 0.050 |
Why?
|
Quality Improvement | 1 | 2015 | 3801 | 0.040 |
Why?
|
Spinal Cord Injuries | 1 | 2008 | 924 | 0.040 |
Why?
|
Physics | 1 | 2020 | 91 | 0.040 |
Why?
|
Spinal Cord | 1 | 2008 | 1807 | 0.040 |
Why?
|
Quality Assurance, Health Care | 1 | 2010 | 2164 | 0.040 |
Why?
|
Computer Simulation | 2 | 2010 | 6233 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 4849 | 0.040 |
Why?
|
ROC Curve | 2 | 2019 | 3575 | 0.040 |
Why?
|
Prevalence | 1 | 2016 | 15702 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2015 | 8542 | 0.040 |
Why?
|
Mutation | 3 | 2020 | 30015 | 0.040 |
Why?
|
Cerebrovascular Circulation | 1 | 2009 | 2726 | 0.040 |
Why?
|
Exostoses | 1 | 2007 | 30 | 0.040 |
Why?
|
Depression | 1 | 2017 | 8132 | 0.040 |
Why?
|
Radiography, Panoramic | 1 | 2007 | 118 | 0.040 |
Why?
|
Parotid Region | 1 | 2007 | 1 | 0.040 |
Why?
|
Laparoscopy | 1 | 2009 | 2030 | 0.040 |
Why?
|
Adipose Tissue | 1 | 2009 | 3310 | 0.040 |
Why?
|
Phantoms, Imaging | 2 | 2017 | 2518 | 0.040 |
Why?
|
Ultrasonography, Doppler | 1 | 2019 | 462 | 0.040 |
Why?
|
Transcription Factor TFIIIA | 1 | 2016 | 24 | 0.040 |
Why?
|
Lymphangioma, Cystic | 1 | 2007 | 34 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3245 | 0.030 |
Why?
|
Mandibular Diseases | 1 | 2007 | 119 | 0.030 |
Why?
|
Administration, Oral | 2 | 2017 | 4010 | 0.030 |
Why?
|
Observer Variation | 2 | 2015 | 2607 | 0.030 |
Why?
|
Leucovorin | 1 | 2018 | 643 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2016 | 106 | 0.030 |
Why?
|
Deoxycytidine | 2 | 2012 | 878 | 0.030 |
Why?
|
Drug Substitution | 1 | 2019 | 290 | 0.030 |
Why?
|
Postoperative Period | 1 | 2021 | 1812 | 0.030 |
Why?
|
Quality of Life | 1 | 2017 | 13359 | 0.030 |
Why?
|
Animals | 5 | 2017 | 168202 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1835 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2018 | 546 | 0.030 |
Why?
|
Mediastinum | 1 | 2007 | 266 | 0.030 |
Why?
|
Pelvis | 1 | 2020 | 732 | 0.030 |
Why?
|
Radiotherapy Dosage | 2 | 2013 | 2897 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2017 | 677 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2018 | 558 | 0.030 |
Why?
|
Postoperative Complications | 5 | 2017 | 15609 | 0.030 |
Why?
|
Tomography, Spiral Computed | 1 | 2006 | 273 | 0.030 |
Why?
|
Parotid Neoplasms | 1 | 2006 | 157 | 0.030 |
Why?
|
Pregnancy | 1 | 2016 | 29869 | 0.030 |
Why?
|
Temporomandibular Joint Disorders | 1 | 2007 | 222 | 0.030 |
Why?
|
Child, Preschool | 1 | 2017 | 42193 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17878 | 0.030 |
Why?
|
Gene Fusion | 1 | 2016 | 356 | 0.030 |
Why?
|
Pharynx | 1 | 2006 | 432 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1700 | 0.030 |
Why?
|
Fluorouracil | 1 | 2018 | 1642 | 0.030 |
Why?
|
Workflow | 1 | 2018 | 849 | 0.030 |
Why?
|
Intra-Abdominal Fat | 1 | 2018 | 612 | 0.030 |
Why?
|
Equipment Failure | 1 | 2015 | 577 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2017 | 13383 | 0.030 |
Why?
|
Drug Resistance | 1 | 2019 | 1594 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 9171 | 0.030 |
Why?
|
Fluorine Radioisotopes | 1 | 2015 | 418 | 0.030 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2012 | 110 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 2017 | 1118 | 0.030 |
Why?
|
Diarrhea | 1 | 2019 | 1317 | 0.020 |
Why?
|
Neck | 1 | 2007 | 734 | 0.020 |
Why?
|
Ileus | 1 | 2012 | 66 | 0.020 |
Why?
|
Creatinine | 1 | 2017 | 1895 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2016 | 1034 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2020 | 2160 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2018 | 2191 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2018 | 10429 | 0.020 |
Why?
|
Stomach | 1 | 2013 | 696 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4036 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2012 | 412 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3370 | 0.020 |
Why?
|
Radiography | 2 | 2010 | 6961 | 0.020 |
Why?
|
Adiposity | 1 | 2018 | 1879 | 0.020 |
Why?
|
Gastroscopy | 1 | 2010 | 211 | 0.020 |
Why?
|
Emergency Service, Hospital | 2 | 2018 | 7873 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 26065 | 0.020 |
Why?
|
Body Mass Index | 2 | 2018 | 12942 | 0.020 |
Why?
|
Muscular Diseases | 1 | 2012 | 552 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2012 | 2214 | 0.020 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2013 | 801 | 0.020 |
Why?
|
Leg | 1 | 2012 | 1087 | 0.020 |
Why?
|
Electromyography | 1 | 2012 | 1392 | 0.020 |
Why?
|
Pressure | 1 | 2010 | 1150 | 0.020 |
Why?
|
Stroke | 1 | 2009 | 9715 | 0.020 |
Why?
|
Preoperative Care | 1 | 2015 | 2242 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12719 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2010 | 1369 | 0.020 |
Why?
|
Microvessels | 1 | 2010 | 577 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4172 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2012 | 1191 | 0.020 |
Why?
|
India | 1 | 2002 | 2286 | 0.020 |
Why?
|
Physical Examination | 1 | 2012 | 1254 | 0.020 |
Why?
|
Endosonography | 1 | 2009 | 608 | 0.020 |
Why?
|
Embolization, Therapeutic | 1 | 2015 | 1418 | 0.020 |
Why?
|
Perfusion | 1 | 2010 | 1373 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 3447 | 0.020 |
Why?
|
Diabetes Complications | 1 | 2012 | 1315 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2018 | 3077 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2015 | 3492 | 0.010 |
Why?
|
Program Evaluation | 1 | 2002 | 2486 | 0.010 |
Why?
|
Demography | 1 | 2008 | 1643 | 0.010 |
Why?
|
Models, Animal | 1 | 2009 | 2108 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10072 | 0.010 |
Why?
|
Head and Neck Neoplasms | 1 | 2007 | 2894 | 0.010 |
Why?
|
Palliative Care | 1 | 2017 | 3593 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2015 | 2634 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13495 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6223 | 0.010 |
Why?
|
Body Weight | 1 | 2012 | 4615 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2009 | 15829 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2010 | 18220 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2009 | 6807 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6473 | 0.010 |
Why?
|
Recovery of Function | 1 | 2008 | 2977 | 0.010 |
Why?
|
Pain | 1 | 2012 | 5062 | 0.010 |
Why?
|
Hemorrhage | 1 | 2008 | 3418 | 0.010 |
Why?
|
Pilot Projects | 1 | 2008 | 8619 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2009 | 12448 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12043 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9417 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2008 | 22153 | 0.010 |
Why?
|